Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with diabetes or heart diseases is not associated with increased risk of optic nerve or vision-threatening events, and plays a role in improving the long-term success rate of curative catheter ablation for atrial fibrillation (AF) in cardiac patients with obesity, researchers from the University of Hong Kong (HKU) have found.
